Related Experiment Videos
Ovarian carcinoma causing cerebellar degeneration
1Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|December 28, 1992
Summary
Subacute cerebellar degeneration may signal underlying cancers. For gynecological tumors, detecting Purkinje cell cytoplasmic antibodies in serum can help identify the malignancy.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Subacute cerebellar degeneration (SCD) is a rare neurological disorder.
- It can be paraneoplastic, meaning associated with an underlying malignancy.
- Gynecological cancers are among the potential causes of paraneoplastic SCD.
Observation:
- Patients with paraneoplastic SCD associated with gynecological tumors often present with specific autoantibodies.
- Purkinje cell cytoplasmic antibodies (PCCAs) are frequently detected in the serum of these patients.
- These antibodies target proteins within the Purkinje cells of the cerebellum.
Findings:
- Purkinje cell cytoplasmic antibodies (PCCAs) in serum are a significant indicator of an underlying gynecological malignancy in cases of subacute cerebellar degeneration.
- The presence and titer of PCCAs correlate with the tumor burden and response to treatment.
- PCCAs function as specific tumor markers for gynecological cancers presenting with neurological autoimmunity.
Implications:
- Early detection of gynecological cancers is possible through serological testing for PCCAs in patients with unexplained subacute cerebellar degeneration.
- This diagnostic approach can improve patient outcomes by enabling timely oncological intervention.
- Understanding the immunological link between gynecological tumors and cerebellar degeneration aids in developing targeted therapies.